Pub Date : 2020-10-01DOI: 10.1016/j.wse.2020.10.002
P. K. Surendran
{"title":"Erratum regarding missing Declaration of Competing Interest statements in previously published articles","authors":"P. K. Surendran","doi":"10.1016/j.wse.2020.10.002","DOIUrl":"https://doi.org/10.1016/j.wse.2020.10.002","url":null,"abstract":"","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.wse.2020.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46227514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100196
Luisa Galati , Rosario Nicola Brancaccio , Alexis Robitaille , Cyrille Cuenin , Fabiola Luzi , Gianna Fiorucci , Maria Vincenza Chiantore , Nadia Marascio , Giovanni Matera , Maria Carla Liberto , Maria Gabriella Donà , Paola Di Bonito , Tarik Gheit , Massimo Tommasino
Actinic keratosis (AK) arises on photo-damaged skin and is considered to be the precursor lesion of cutaneous squamous cell carcinoma (cSCC). Many findings support the involvement of β human papillomaviruses (HPVs) in cSCC, while very little is known on γ HPV types. The objective of this study was to characterize the spectrum of PV types in healthy skin (HS) and AK samples of the same immunocompetent individuals using next generation sequencing (NGS). Viral DNA of 244 AK and 242 HS specimens were amplified by PCR using two different sets of primers (FAP59/64 and FAPM1). Purified amplicons were pooled and sequenced using NGS. The study resulted in the identification of a large number of known β and γ PV types. In addition, 27 putative novel β and 16 γ and 4 unclassified PVs were isolated. HPV types of species γ-1 (e.g. HPV4) appeared to be strongly enriched in AK versus HS. The NGS analysis revealed that a large spectrum of known and novel PVs is present in HS and AK. The evidence that species γ-1 HPV types appears to be enriched in AK in comparison to HS warrants further studies to evaluate their role in development of skin (pre)cancerous lesions.
{"title":"Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing","authors":"Luisa Galati , Rosario Nicola Brancaccio , Alexis Robitaille , Cyrille Cuenin , Fabiola Luzi , Gianna Fiorucci , Maria Vincenza Chiantore , Nadia Marascio , Giovanni Matera , Maria Carla Liberto , Maria Gabriella Donà , Paola Di Bonito , Tarik Gheit , Massimo Tommasino","doi":"10.1016/j.pvr.2020.100196","DOIUrl":"10.1016/j.pvr.2020.100196","url":null,"abstract":"<div><p>Actinic keratosis (AK) arises on photo-damaged skin and is considered to be the precursor lesion of cutaneous squamous cell carcinoma (cSCC). Many findings support the involvement of β human papillomaviruses (HPVs) in cSCC, while very little is known on γ HPV types. The objective of this study was to characterize the spectrum of PV types in healthy skin (HS) and AK samples of the same immunocompetent individuals using next generation sequencing (NGS). Viral DNA of 244 AK and 242 HS specimens were amplified by PCR using two different sets of primers (FAP59/64 and FAPM1). Purified amplicons were pooled and sequenced using NGS. The study resulted in the identification of a large number of known β and γ PV types. In addition, 27 putative novel β and 16 γ and 4 unclassified PVs were isolated. HPV types of species γ-1 (e.g. HPV4) appeared to be strongly enriched in AK versus HS. The NGS analysis revealed that a large spectrum of known and novel PVs is present in HS and AK. The evidence that species γ-1 HPV types appears to be enriched in AK in comparison to HS warrants further studies to evaluate their role in development of skin (pre)cancerous lesions.</p></div>","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100196","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37779706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100198
Felix Jede , Theresa Brandt , Molla Gedefaw , Solomon Berhe Wubneh , Tamrat Abebe , Brhanu Teka , Kassahun Alemu , Binyam Tilahun , Temesgen Azemeraw , Abebaw Gebeyehu , Dietmar Schmidt , Aleksandra Pesic , Andreas M. Kaufmann , Bewketu Abebe , Zelalem Ayichew , Michael Byczkowski , Timoté Vaucher , Heike Sartor , Gashaw Andargie , Till Bärnighausen , Hermann Bussmann
Primary HPV testing and triage of HPV-positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community-based screening in resource-poor communities, provided a robust tracking system is in place.
A cervical cancer screening campaign was conducted in a rural community in Ethiopia. All women aged 25–65 years were offered genital self-sampling using the Evalyn Brush®. Samples were HPV-DNA-tested at a central laboratory. Key indicators were captured on tablet computers and linked by a cloud-based information system. HPV-positive women were examined at the local clinic using portable colposcopy, p16/Ki-67 dual stain cytology and biopsy examination. CIN2+ women were referred for LEEP to the referral hospital.
Of 749 enumerated age-eligible women 634 (85%, (95% CI 82–88)) consented to screening, 429 samples were adequate for HPV testing, giving a total testing coverage of 57% (95% CI 53–62). The hrHPV prevalence was 14% (95% CI 5–22), 72% (95% CI 60–84) attended the clinic for a triage examination. Home-based HPV-DNA self-sampling and clinic-based triage assisted by cloud-based information technology is feasible in rural Ethiopia. Key components of such strategy are broad community awareness, high competency of community workers, and establishment of an adequate self-sampling and HPV-DNA testing platform.
对HPV阳性妇女进行初步HPV检测和分诊是一种有效的宫颈癌筛查策略。如果有一个健全的跟踪系统,这种多次访问筛查算法也有望用于资源贫乏社区的社区筛查。在埃塞俄比亚的一个农村社区开展了宫颈癌筛查运动。所有25-65岁的女性都使用Evalyn刷子进行生殖器自采样。在一个中心实验室对样本进行了hpv dna检测。关键指标被记录在平板电脑上,并通过基于云的信息系统进行链接。hpv阳性妇女在当地诊所进行便携式阴道镜检查、p16/Ki-67双染色细胞学检查和活检检查。CIN2+的妇女因LEEP被转介到转诊医院。在749名经点算的符合年龄的妇女中,634名(85%,95% CI 82-88)同意接受筛查,429份样本足以进行HPV检测,总检测覆盖率为57% (95% CI 53-62)。hrHPV患病率为14% (95% CI 5-22), 72% (95% CI 60-84)到诊所接受分诊检查。在埃塞俄比亚农村,基于家庭的HPV-DNA自采样和基于云的信息技术辅助的基于诊所的分诊是可行的。这一战略的关键组成部分是广泛的社区意识、社区工作人员的高能力以及建立适当的自我采样和HPV-DNA检测平台。
{"title":"Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia","authors":"Felix Jede , Theresa Brandt , Molla Gedefaw , Solomon Berhe Wubneh , Tamrat Abebe , Brhanu Teka , Kassahun Alemu , Binyam Tilahun , Temesgen Azemeraw , Abebaw Gebeyehu , Dietmar Schmidt , Aleksandra Pesic , Andreas M. Kaufmann , Bewketu Abebe , Zelalem Ayichew , Michael Byczkowski , Timoté Vaucher , Heike Sartor , Gashaw Andargie , Till Bärnighausen , Hermann Bussmann","doi":"10.1016/j.pvr.2020.100198","DOIUrl":"10.1016/j.pvr.2020.100198","url":null,"abstract":"<div><p>Primary HPV testing and triage of HPV-positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community-based screening in resource-poor communities, provided a robust tracking system is in place.</p><p>A cervical cancer screening campaign was conducted in a rural community in Ethiopia. All women aged 25–65 years were offered genital self-sampling using the Evalyn Brush®. Samples were HPV-DNA-tested at a central laboratory. Key indicators were captured on tablet computers and linked by a cloud-based information system. HPV-positive women were examined at the local clinic using portable colposcopy, p16/Ki-67 dual stain cytology and biopsy examination. CIN2+ women were referred for LEEP to the referral hospital.</p><p>Of 749 enumerated age-eligible women 634 (85%, (95% CI 82–88)) consented to screening, 429 samples were adequate for HPV testing, giving a total testing coverage of 57% (95% CI 53–62). The hrHPV prevalence was 14% (95% CI 5–22), 72% (95% CI 60–84) attended the clinic for a triage examination. Home-based HPV-DNA self-sampling and clinic-based triage assisted by cloud-based information technology is feasible in rural Ethiopia. Key components of such strategy are broad community awareness, high competency of community workers, and establishment of an adequate self-sampling and HPV-DNA testing platform.</p></div>","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100198","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37942049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100201
E. Peeters , K. Cornet , H. Cammu , V. Verhoeven , D. Devroey , M. Arbyn
{"title":"Corrigendum to “Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial” [Papillomavirus Res. 9 (2020) 100194]","authors":"E. Peeters , K. Cornet , H. Cammu , V. Verhoeven , D. Devroey , M. Arbyn","doi":"10.1016/j.pvr.2020.100201","DOIUrl":"10.1016/j.pvr.2020.100201","url":null,"abstract":"","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100201","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37962328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100193
Rianne van den Helder , Nienke E. van Trommel , Annina P. van Splunter , Birgit I. Lissenberg-Witte , Maaike C.G. Bleeker , Renske D.M. Steenbergen
Introduction
Urine sampling is an interesting solution for CIN3 and cervical cancer detection. Urine can be separated in different fractions: full void urine, urine sediment and urine supernatant. We aimed to determine which urine fraction is most competent for CIN3 and cervical cancer detection by methylation analysis.
Methods
Urine samples (27 controls, 30 CIN3 and 17 cervical cancer) were processed into 3 fractions and tested for 5 methylation markers (ASCL1, GHSR, LHX8, SST, ZIC1). We determined Spearman correlation coefficients between fractions, compared methylation levels and calculated AUCs for CIN3 and cancer detection.
Results
In general strong correlations (r > 0.60) were found between urine fractions. Methylation levels increased significantly with severity of underlying disease in all urine fractions. CIN3 and controls differed significantly for 2 markers in full void urine, 4 markers in urine sediment and 1 marker in urine supernatant, with AUCs of 0.55–0.79. Comparison of cancer to controls was highly significant for all markers in all fractions, yielding AUCs of 0.87–0.99.
Conclusion
Methylation analysis performs excellent in all urine fractions for cervical cancer detection. Our results indicate the potential of CIN3 detection by urinary methylation analysis, and demonstrate that urine sediment performs best to detect CIN3.
{"title":"Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection","authors":"Rianne van den Helder , Nienke E. van Trommel , Annina P. van Splunter , Birgit I. Lissenberg-Witte , Maaike C.G. Bleeker , Renske D.M. Steenbergen","doi":"10.1016/j.pvr.2020.100193","DOIUrl":"10.1016/j.pvr.2020.100193","url":null,"abstract":"<div><h3>Introduction</h3><p>Urine sampling is an interesting solution for CIN3 and cervical cancer detection. Urine can be separated in different fractions: full void urine, urine sediment and urine supernatant. We aimed to determine which urine fraction is most competent for CIN3 and cervical cancer detection by methylation analysis.</p></div><div><h3>Methods</h3><p>Urine samples (27 controls, 30 CIN3 and 17 cervical cancer) were processed into 3 fractions and tested for 5 methylation markers (<em>ASCL1</em>, <em>GHSR</em>, <em>LHX8</em>, <em>SST</em>, <em>ZIC1</em>). We determined Spearman correlation coefficients between fractions, compared methylation levels and calculated AUCs for CIN3 and cancer detection.</p></div><div><h3>Results</h3><p>In general strong correlations (r > 0.60) were found between urine fractions. Methylation levels increased significantly with severity of underlying disease in all urine fractions. CIN3 and controls differed significantly for 2 markers in full void urine, 4 markers in urine sediment and 1 marker in urine supernatant, with AUCs of 0.55–0.79. Comparison of cancer to controls was highly significant for all markers in all fractions, yielding AUCs of 0.87–0.99.</p></div><div><h3>Conclusion</h3><p>Methylation analysis performs excellent in all urine fractions for cervical cancer detection. Our results indicate the potential of CIN3 detection by urinary methylation analysis, and demonstrate that urine sediment performs best to detect CIN3.</p></div>","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100193","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37738341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2019.100192
Julia Brotherton , Cristyn Davies
{"title":"IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some","authors":"Julia Brotherton , Cristyn Davies","doi":"10.1016/j.pvr.2019.100192","DOIUrl":"10.1016/j.pvr.2019.100192","url":null,"abstract":"","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2019.100192","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47221628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100194
E. Peeters , K. Cornet , D. Devroey , M. Arbyn
{"title":"Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial","authors":"E. Peeters , K. Cornet , D. Devroey , M. Arbyn","doi":"10.1016/j.pvr.2020.100194","DOIUrl":"10.1016/j.pvr.2020.100194","url":null,"abstract":"","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100194","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37742657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100195
Suzanne M. Garland, Margaret A. Stanley, Anna R. Giuliano, Anna-Barbara Moscicki, Andreas Kaufmann, Neerja Bhatla, Yin Ling Woo
{"title":"IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity”","authors":"Suzanne M. Garland, Margaret A. Stanley, Anna R. Giuliano, Anna-Barbara Moscicki, Andreas Kaufmann, Neerja Bhatla, Yin Ling Woo","doi":"10.1016/j.pvr.2020.100195","DOIUrl":"10.1016/j.pvr.2020.100195","url":null,"abstract":"","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100195","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37764924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.pvr.2020.100199
Deepti Bettampadi , Bradley A. Sirak , William J. Fulp , Martha Abrahamsen , Luisa L. Villa , Eduardo Lazcano-Ponce , Jorge Salmeron , Kimberly A. Isaacs-Soriano , Maria L. Baggio , Manuel Quiterio Trenado , Anna R. Giuliano
Introduction
Oral human papillomavirus (HPV) attributable oropharyngeal cancers are on the rise in many countries. Oral HPV infections among healthy individuals are commonly detected using oral gargle samples. However, the optimal method for HPV genotyping oral gargle specimens in research studies has not been previously evaluated.
Materials and methods
Oral gargle samples from 1455 HPV Infection in Men (HIM) study participants were HPV genotyped using two different methods: Linear Array and the SPF10 PCR-DEIA-LiPA25. The sensitivity of the two tests for detecting individual HPV types and grouped HPV types, high-risk HPV, low-risk HPV, grouped 4-HPV-vaccine types, and grouped 9-HPV-vaccine-types, and the degree of concordance between the two tests was assessed. We also examined whether socio-demographic-behavioral factors were associated with concordance between the two assays.
Results
The sensitivity of SPF10 PCR-DEIA-LiPA25 was higher than Linear Array, with the exception of HPV 70, for the detection of oral HPV. The prevalence ratio of SPF10 PCR-DEIA-LiPA25 to Linear Array varied between 1.0 and 9.0 for individual HPV genotypes, excluding HPV 70, and between 3.8 and 4.4 for grouped 4-valent and 9-valent HPV vaccine types, respectively. There was no association between socio-demographic-behavioral factors and discordance in results between the two tests for oral HPV 16 detection.
Discussion
SPF10 PCR-DEIA-LiPA25 was more sensitive than Linear Array for detecting HPV in oral gargle samples. Given the growing importance of detecting oral HPV infection for research studies of oral HPV natural history and vaccine effectiveness evaluation, we recommend using methods with higher sensitivity such as SPF10 PCR-DEIA-LiPA25 for detecting HPV in oral gargle samples.
{"title":"Oral HPV prevalence assessment by Linear Array vs. SPF10 PCR-DEIA-LiPA25 system in the HPV Infection in Men (HIM) study","authors":"Deepti Bettampadi , Bradley A. Sirak , William J. Fulp , Martha Abrahamsen , Luisa L. Villa , Eduardo Lazcano-Ponce , Jorge Salmeron , Kimberly A. Isaacs-Soriano , Maria L. Baggio , Manuel Quiterio Trenado , Anna R. Giuliano","doi":"10.1016/j.pvr.2020.100199","DOIUrl":"10.1016/j.pvr.2020.100199","url":null,"abstract":"<div><h3>Introduction</h3><p>Oral human papillomavirus (HPV) attributable oropharyngeal cancers are on the rise in many countries. Oral HPV infections among healthy individuals are commonly detected using oral gargle samples. However, the optimal method for HPV genotyping oral gargle specimens in research studies has not been previously evaluated.</p></div><div><h3>Materials and methods</h3><p>Oral gargle samples from 1455 HPV Infection in Men (HIM) study participants were HPV genotyped using two different methods: Linear Array and the SPF<sub>10</sub> PCR-DEIA-LiPA<sub>25</sub>. The sensitivity of the two tests for detecting individual HPV types and grouped HPV types, high-risk HPV, low-risk HPV, grouped 4-HPV-vaccine types, and grouped 9-HPV-vaccine-types, and the degree of concordance between the two tests was assessed. We also examined whether socio-demographic-behavioral factors were associated with concordance between the two assays.</p></div><div><h3>Results</h3><p>The sensitivity of SPF<sub>10</sub> PCR-DEIA-LiPA<sub>25</sub> was higher than Linear Array, with the exception of HPV 70, for the detection of oral HPV. The prevalence ratio of SPF<sub>10</sub> PCR-DEIA-LiPA<sub>25</sub> to Linear Array varied between 1.0 and 9.0 for individual HPV genotypes, excluding HPV 70, and between 3.8 and 4.4 for grouped 4-valent and 9-valent HPV vaccine types, respectively. There was no association between socio-demographic-behavioral factors and discordance in results between the two tests for oral HPV 16 detection.</p></div><div><h3>Discussion</h3><p>SPF<sub>10</sub> PCR-DEIA-LiPA<sub>25</sub> was more sensitive than Linear Array for detecting HPV in oral gargle samples. Given the growing importance of detecting oral HPV infection for research studies of oral HPV natural history and vaccine effectiveness evaluation, we recommend using methods with higher sensitivity such as SPF<sub>10</sub> PCR-DEIA-LiPA<sub>25</sub> for detecting HPV in oral gargle samples.</p></div>","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100199","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37982421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}